A candidate androgen signaling signature predictive of response to Abiraterone acetate in men with metastatic castration resistant prostate cancer

BACKGROUND: The unmet need for predictive biomarkers emerged from the unpredictable pattern of response to androgen signaling inhibition in metastatic castration-resistant prostate cancer (mCRPC). Here, we report on the testing of a previously identified candidate androgen signaling signature associ...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Eur J Cancer
Autors principals: Boukovala, M., Spetsieris, N., Weldon, J. A., Tsikkinis, A., Hoang, A., Aparicio, A., Tu, SM., Araujo, J.C., Zurita, A. J., Corn, P., Pagliaro, L., Kim, J., Wang, J., Subudhi, S., Tannir, N., Logothetis, C. J., Troncoso, P., Wen, S., Efstathiou, E.
Format: Artigo
Idioma:Inglês
Publicat: 2020
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7350510/
https://ncbi.nlm.nih.gov/pubmed/31986451
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ejca.2019.12.027
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars